XCUR — Exicure, Inc.
BiotechnologyHealthcare
$1.08
+$0.02 (+1.89%)
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets.
Market Cap
$7.07M
Forward P/E
-1.4x
52-Week Range
N/A
XCUR Price History
No cached price history available for this ticker yet.
Revenue vs. Net Income
-$483K
Revenue · FY2021
Annual. Net margin is shown under each year.
RevenueNet income (green profit, red loss)
Free Cash Flow
Annual. FCF margin is shown under each year.
No cash flow statement data available for this ticker yet.
Return on Capital Employed (ROCE)
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
No balance sheet data available to compute ROCE for this ticker yet.
Total Assets vs. Total Liabilities
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
Total assetsTotal liabilities
No balance sheet data available for this ticker yet.
CapEx as % of Revenue
Annual. Green at or under the 5% maximum target, red above it.
No cash flow statement data available for this ticker yet.
Shares Outstanding
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
No share-count history available for this ticker yet.
